通用名称

deferasirox

儿科标签批准日期

2018/12/12 0:00:00

特定指示/秒

Transfusion-dependent anemia requiring chelation therapy due to iron overload

标签更改摘要

- A trial conducted in treatment naïve pediatric patients, ages 2 years to less than 18 years with transfusional iron overload did not include a sufficient number of patients to provide additional meaningful information about the safety or compliance of the deferasirox oral tablet for suspension dosage form (Exjade) compared to the deferasirox granules dosage form (Jadenu Sprinkle).

治疗类别

N/A

立法类型

BPCA Only

产品说明书链接